Magnetic Electrospun Micro-fibre Scaffold Assemblies: Examples of Their Use for 3-Dimensional Cell-Based Screening Applications
Time: 11:50 am - 12:10 pm
Date: 28 April 2020
After gaining his Ph.D. from Edinburgh University in 1990, Gary joined Hoffmann La Roche (USA) to investigate retinoid pharmacology and the role of nuclear hormone receptors in foetal development. He then worked for GSK (UK) in 1995, gaining expertise in the development of cell-based assays within the CNS disease area as well as novel drug discovery assay technologies. Thereafter, Gary spent over 10 years at AstraZeneca (UK), developing novel cell-culture robotics and evaluating and implementing new assay technologies for respiratory and inflammatory diseases, before founding Aurelia Bioscience, a UK based Contract Research Organisation specialising in bioassay development and compound screening.
- Dr Gary Allenby Chief Scientific Officer - Aurelia Bioscience